GlobeNewswire
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
📈
AI Sentiment
Highly Positive
8/10
Calidi Biotherapeutics Inc. News
Latest updates and market news for CLDI
1 news
Feb 19 - Feb 25, 2026
Page 1
Share this news page